Finally, we show that PI3K likely functions in BCC tumors by promoting aPKC- and AKT1-depedent degradation of cyclin-dependent kinase inhibitor p21 to maintain cell cycle progression. Here, AKT1 is linked to skin basal cell carcinoma.